Given the widespread market volatility, some investors are seeking refuge in more defensible stocks. However, this certainly doesn’t apply to every Wall Street …
Along with healthcare stocks in general, biotechnology stocks are not hitting any near-term highs in terms of share price performance. Chalk it up …
Foamix Pharmaceuticals (FOMX) may be the best drug stock opportunity you’ve never heard of — and you should probably prepare yourself to hear …
Foamix (FOMX) hasn’t had a great year, with shares falling 33% since the start of 2019. But things aren’t as bad as they …
Investment banker Barclays announced it has initiated coverage of 20 U.S.
Get ready, bargain shoppers. Foamix (FOMX) has plummeted 27% since the beginning of the year and it looks like the stock received more …
In a research report issued today, Oppenheimer analyst Akiva Felt initiated coverage with an Outperform rating on Foamix Pharmaceuticals (NASDAQ:FOMX) and a $15 price target, which represents …
